U.S. Markets open in 9 hrs 29 mins

[$$] If This Is Failure, Show Me Success

In a nearly 200-page presentation calling for investors to reject Bristol-Myers Squibb’s proposed acquisition of Celgene released on Monday, activist hedge fund Starboard Value called Celgene’s pipeline of new drugs “unproven.